These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23078059)

  • 1. 8th International Congress on Autoimmunity: new perspectives for refractory catastrophic antiphospholipid syndrome.
    Cervera R
    Expert Rev Clin Immunol; 2012 Sep; 8(7):617-9. PubMed ID: 23078059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity in focus: from mechanisms to treatment.
    Kon Y
    Expert Rev Clin Immunol; 2012 May; 8(4):333-5. PubMed ID: 22607179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of refractory cases of catastrophic antiphospholipid syndrome.
    Espinosa G; Berman H; Cervera R
    Autoimmun Rev; 2011 Sep; 10(11):664-8. PubMed ID: 21569863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome.
    Sciascia S; Naretto C; Rossi D; Bazzan M; Roccatello D
    Lupus; 2011 Oct; 20(10):1106-8. PubMed ID: 21652607
    [No Abstract]   [Full Text] [Related]  

  • 5. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
    Cervera R; Rodríguez-Pintó I; Colafrancesco S; Conti F; Valesini G; Rosário C; Agmon-Levin N; Shoenfeld Y; Ferrão C; Faria R; Vasconcelos C; Signorelli F; Espinosa G
    Autoimmun Rev; 2014 Jul; 13(7):699-707. PubMed ID: 24657970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Catastrophic antiphospholipid syndrome. Case report and literature review].
    del Carpio-Orantes L; Martínez-Anaya CC; Bonilla-Casas E
    Gac Med Mex; 2017; 153(4):531-536. PubMed ID: 28991291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catastrophic Antiphospholipid Syndrome: Candidate Therapies for a Potentially Lethal Disease.
    Unlu O; Erkan D
    Annu Rev Med; 2017 Jan; 68():287-296. PubMed ID: 28099080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiphospholipid antibodies and antiphospholipid syndrome: diagnosis and management].
    García-García C
    Actas Dermosifiliogr; 2007; 98(1):16-23. PubMed ID: 17374329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid syndrome: state of the art with emphasis on laboratory evaluation.
    Greaves M
    Haemostasis; 2000; 30 Suppl 2():16-25. PubMed ID: 11251337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies and thrombosis.
    Gleicher N; Coulam C
    Lancet; 1999 Jul; 354(9172):72-3. PubMed ID: 10406388
    [No Abstract]   [Full Text] [Related]  

  • 11. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms.
    Erkan D; Espinosa G; Cervera R
    Autoimmun Rev; 2010 Dec; 10(2):74-9. PubMed ID: 20696282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conference scene: the 4th Asian Congress on Autoimmunity: meeting highlights. 11-13 September, 2009, Singapore.
    Mehra N; Kumar N
    Immunotherapy; 2010 Mar; 2(2):145-50. PubMed ID: 20635922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conference scene: shining lights on the future of autoimmunity in Asia.
    Perricone C; Perricone R
    Immunotherapy; 2012 Mar; 4(3):263-7. PubMed ID: 22401631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.
    Berman H; Rodríguez-Pintó I; Cervera R; Morel N; Costedoat-Chalumeau N; Erkan D; Shoenfeld Y; Espinosa G;
    Autoimmun Rev; 2013 Sep; 12(11):1085-90. PubMed ID: 23777822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity in thrombotic thrombocytopenic purpura.
    Porta C; Caporali R; Montecucco C
    Semin Thromb Hemost; 2005 Dec; 31(6):633-40. PubMed ID: 16388414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V meeting of the European forum on antiphospholipid antibodies.
    Cervera R; Font J; Tincani A; Boffa MC
    Autoimmun Rev; 2006 Aug; 5(7):499-507. PubMed ID: 16920577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and classification of the antiphospholipid syndrome.
    Gómez-Puerta JA; Cervera R
    J Autoimmun; 2014; 48-49():20-5. PubMed ID: 24461539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Networking in Europe for special centres of excellence for autoimmune diseases.
    Vasconcelos C; Cervera R
    Lupus; 2009 Sep; 18(10):930-2. PubMed ID: 19671795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 6th Autoimmunity Congress: meeting highlights. 6th International Congress on Autoimmunity, 9-13 September 2008, Porto, Portugal.
    Ben-Ami Shor D; Zandman-Goddard G
    Immunotherapy; 2009 Mar; 1(2):171-6. PubMed ID: 20635937
    [No Abstract]   [Full Text] [Related]  

  • 20. Catastrophic antiphospholipid syndrome: The current management approach.
    Rodriguez-Pintó I; Espinosa G; Cervera R
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):239-249. PubMed ID: 27886797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.